These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6208336)

  • 41. Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia.
    Arai H; Emson PC; Mountjoy CQ; Carassco LH; Heizmann CW
    Brain Res; 1987 Aug; 418(1):164-9. PubMed ID: 3311290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication.
    Chen CP; Alder JT; Bowen DM; Esiri MM; McDonald B; Hope T; Jobst KA; Francis PT
    J Neurochem; 1996 Apr; 66(4):1592-8. PubMed ID: 8627315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential photoaffinity labelling of serotonin-S2 receptors and histamine-H1 receptors using 7-azidoketanserin.
    Wouters W; Van Dun J; Leysen JE; Laduron PM
    FEBS Lett; 1985 Mar; 182(2):291-6. PubMed ID: 3979551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK; Maloteaux JM; Laduron PM
    J Neurochem; 1984 Oct; 43(4):1068-71. PubMed ID: 6088690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 46. An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia.
    Cross AJ; Slater P; Perry EK; Perry RH
    Neurochem Int; 1988; 13(1):89-96. PubMed ID: 20501276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 48. Solubilization of rat brain serotonin-S2 receptors using CHAPS/salt.
    Wouters W; Van Dun J; Leysen JE; Laduron PM
    Eur J Pharmacol; 1985 Sep; 115(1):1-9. PubMed ID: 2931292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia.
    Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Heizmann CW
    Brain Res; 1988 Dec; 475(1):156-9. PubMed ID: 3214722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.
    Palmer AM; Francis PT; Benton JS; Sims NR; Mann DM; Neary D; Snowden JS; Bowen DM
    J Neurochem; 1987 Jan; 48(1):8-15. PubMed ID: 2432177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
    Middlemiss DN; Palmer AM; Edel N; Bowen DM
    J Neurochem; 1986 Mar; 46(3):993-6. PubMed ID: 2419502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cortical neurochemistry in Alzheimer-type dementia.
    Cross AJ; Crow TJ; Peters TJ
    Prog Brain Res; 1986; 70():153-69. PubMed ID: 3033741
    [No Abstract]   [Full Text] [Related]  

  • 53. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
    Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
    Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T; Alufuzoff I; Winblad B; Nordberg A
    Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients.
    Iwamoto N; Kobayashi K; Kosaka K
    J Neurol; 1989 Feb; 236(2):80-4. PubMed ID: 2709057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D; Pazos A; Probst A; Palacios JM
    Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.
    Lai MK; Tsang SW; Francis PT; Esiri MM; Keene J; Hope T; Chen CP
    Brain Res; 2003 Jun; 974(1-2):82-7. PubMed ID: 12742626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
    Garcia-Alloza M; Hirst WD; Chen CP; Lasheras B; Francis PT; Ramírez MJ
    Neuropsychopharmacology; 2004 Feb; 29(2):410-6. PubMed ID: 14571255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex.
    Harkany T; O'Mahony S; Keijser J; Kelly JP; Kónya C; Borostyánkoi ZA; Görcs TJ; Zarándi M; Penke B; Leonard BE; Luiten PG
    Neurobiol Dis; 2001 Aug; 8(4):667-78. PubMed ID: 11493031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age.
    Marcusson JO; Morgan DG; Winblad B; Finch CE
    Brain Res; 1984 Oct; 311(1):51-6. PubMed ID: 6488044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.